TIOTROPIUM BROMIDE

TIOTROPIUM BROMIDE was reported 136782 times

TIOTROPIUM BROMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RIGHT ATRIAL HYPERTROPHY 89 0.8091
1 INCORRECT ROUTE OF DRUG ADMINISTRATION 23320 0.6518
2 TOTAL LUNG CAPACITY INCREASED 154 0.5662
3 SPIROMETRY ABNORMAL 335 0.5602
4 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 274 0.5239
5 CONGENITAL HIATUS HERNIA 115 0.5044
6 MITE ALLERGY 311 0.4748
7 TOTAL LUNG CAPACITY ABNORMAL 160 0.4113
8 DUST ALLERGY 374 0.3812
9 REVERSIBLE AIRWAYS OBSTRUCTION 184 0.3622
10 MYCOTIC ALLERGY 307 0.3591
11 PROLONGED EXPIRATION 92 0.3511
12 BRONCHIAL WALL THICKENING 248 0.3449
13 FORCED EXPIRATORY VOLUME DECREASED 914 0.3223
14 PULMONARY VASCULITIS 161 0.2993
15 DYSPNOEA EXACERBATED 149 0.2893
16 OBSTRUCTIVE AIRWAYS DISORDER 2842 0.2552
17 FORCED VITAL CAPACITY DECREASED 161 0.2466
18 VITAL CAPACITY DECREASED 107 0.2388
19 LUNG HYPERINFLATION 196 0.2279
20 VOCAL CORD DYSFUNCTION 111 0.2252
21 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 208 0.2244
22 EOSINOPHIL COUNT ABNORMAL 164 0.2195
23 RESPIRATORY GAS EXCHANGE DISORDER 80 0.2156
24 CONJUNCTIVITIS ALLERGIC 300 0.2024
25 BLOOD IMMUNOGLOBULIN E INCREASED 481 0.1984
26 LUNG DIFFUSION TEST DECREASED 79 0.1980
27 BRONCHIAL SECRETION RETENTION 245 0.1923
28 PULMONARY FUNCTION TEST ABNORMAL 297 0.1905
29 PEAK EXPIRATORY FLOW RATE DECREASED 82 0.1864
30 SEDATION COMPLICATION 474 0.1856
31 LARYNGEAL STENOSIS 103 0.1782
32 FULL BLOOD COUNT ABNORMAL 1653 0.1561
33 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 111 0.1514
34 ALLERGY TO ANIMAL 161 0.1510
35 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 306 0.1499
36 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2546 0.1498
37 RESTRICTIVE PULMONARY DISEASE 173 0.1476
38 SPUTUM DISCOLOURED 1398 0.1473
39 SPUTUM PURULENT 95 0.1444
40 TOTAL LUNG CAPACITY DECREASED 214 0.1339
41 CREATININE RENAL CLEARANCE DECREASED 496 0.1238
42 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 6316 0.1209
43 BRONCHIECTASIS 792 0.1174
44 WHEEZING 6931 0.1168
45 BRONCHIAL OBSTRUCTION 163 0.1160
46 NEURITIS 173 0.1120
47 BREATH SOUNDS ABNORMAL 536 0.1086
48 RIGHT VENTRICULAR HYPERTROPHY 97 0.1074
49 BRONCHIAL HYPERREACTIVITY 128 0.1064
50 NASAL OBSTRUCTION 192 0.1023
51 NORMOCHROMIC NORMOCYTIC ANAEMIA 304 0.1011
52 MULTIPLE DRUG THERAPY 75 0.0995
53 ASTHMA 11105 0.0982
54 RESPIRATORY SYMPTOM 278 0.0976
55 EMPHYSEMA 982 0.0972
56 SPUTUM RETENTION 96 0.0969
57 INCREASED BRONCHIAL SECRETION 245 0.0957
58 BLOOD COUNT ABNORMAL 1448 0.0954
59 PULMONARY FUNCTION TEST DECREASED 407 0.0929
60 DYSPNOEA PAROXYSMAL NOCTURNAL 65 0.0892
61 NASAL POLYPS 414 0.0840
62 RHONCHI 115 0.0832
63 PRODUCTIVE COUGH 3765 0.0788
64 ASTHMATIC CRISIS 286 0.0782
65 RALES 446 0.0767
66 HYPOVENTILATION 250 0.0766
67 EOSINOPHIL COUNT INCREASED 609 0.0730
68 CHRONIC SINUSITIS 274 0.0729
69 CARBON DIOXIDE INCREASED 98 0.0718
70 BENIGN PROSTATIC HYPERPLASIA 371 0.0718
71 SPUTUM INCREASED 155 0.0716
72 LOWER RESPIRATORY TRACT CONGESTION 117 0.0687
73 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3294 0.0685
74 INCREASED UPPER AIRWAY SECRETION 351 0.0683
75 OESOPHAGEAL SPASM 125 0.0678
76 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1153 0.0672
77 CHEST X-RAY ABNORMAL 206 0.0671
78 NASAL DISCHARGE DISCOLOURATION 91 0.0659
79 AORTIC VALVE STENOSIS 114 0.0639
80 HALO VISION 70 0.0619
81 LUNG OPACITY 163 0.0618
82 BRONCHITIS CHRONIC 147 0.0601
83 DYSPNOEA EXERTIONAL 2227 0.0591
84 RHINITIS ALLERGIC 263 0.0590
85 MALIGNANT MELANOMA IN SITU 72 0.0581
86 NOCTURNAL DYSPNOEA 74 0.0580
87 SENSITIVITY TO WEATHER CHANGE 291 0.0552
88 MYCOBACTERIUM AVIUM COMPLEX INFECTION 147 0.0547
89 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3893 0.0547
90 PULMONARY MASS 790 0.0530
91 RESPIRATORY RATE INCREASED 460 0.0518
92 UPPER-AIRWAY COUGH SYNDROME 426 0.0517
93 PULMONARY CONGESTION 672 0.0509
94 MYCOBACTERIAL INFECTION 86 0.0499
95 DYSPNOEA AT REST 144 0.0497
96 THROAT CLEARING 185 0.0493
97 DIASTOLIC DYSFUNCTION 152 0.0492
98 CANDIDIASIS 196 0.0488
99 OBSTRUCTIVE SLEEP APNOEA SYNDROME 71 0.0487
100 BLOOD CALCIUM DECREASED 533 0.0474
101 MIDDLE INSOMNIA 880 0.0471
102 LUNG INFECTION 716 0.0460
103 OXYGEN SATURATION ABNORMAL 126 0.0444
104 PRODUCT QUALITY ISSUE 5982 0.0440
105 RUBBER SENSITIVITY 66 0.0431
106 PLEURITIC PAIN 118 0.0427
107 RESPIRATION ABNORMAL 291 0.0422
108 HYPERCAPNIA 126 0.0418
109 ARTERIOSCLEROSIS CORONARY ARTERY 277 0.0418
110 SINUS PAIN 97 0.0416
111 PRODUCT PHYSICAL ISSUE 836 0.0414
112 SECRETION DISCHARGE 517 0.0412
113 DRY THROAT 418 0.0411
114 LUNG CONSOLIDATION 115 0.0411
115 NASAL SEPTUM DEVIATION 80 0.0409
116 DYSPHONIA 2391 0.0408
117 OBSTRUCTION 163 0.0408
118 APHONIA 561 0.0402
119 SLEEP APNOEA SYNDROME 766 0.0401
120 DYSPNOEA 22675 0.0400
121 RHINITIS 322 0.0399
122 VOCAL CORD DISORDER 78 0.0395
123 NASAL OEDEMA 71 0.0393
124 HAEMOPTYSIS 1064 0.0381
125 ORTHOSTATIC HYPOTENSION 661 0.0379
126 BLOOD PRESSURE SYSTOLIC INCREASED 732 0.0375
127 ABNORMAL LOSS OF WEIGHT 254 0.0372
128 RESPIRATORY TRACT CONGESTION 589 0.0370
129 ORTHOPNOEA 118 0.0370
130 PULMONARY PAIN 108 0.0370
131 TACHYARRHYTHMIA 90 0.0360
132 BRONCHITIS 2653 0.0358
133 LOBAR PNEUMONIA 66 0.0356
134 ARTERIOSCLEROSIS 333 0.0353
135 EOSINOPHILIA 613 0.0349
136 PROSTATOMEGALY 137 0.0348
137 BODY TEMPERATURE DECREASED 343 0.0348
138 OESOPHAGEAL PAIN 137 0.0346
139 HYPERPARATHYROIDISM SECONDARY 86 0.0343
140 PAINFUL RESPIRATION 82 0.0340
141 SARCOIDOSIS 161 0.0339
142 ORAL CANDIDIASIS 439 0.0333
143 LUNG DISORDER 1611 0.0328
144 NASAL DISORDER 87 0.0327
145 BRONCHOSPASM 460 0.0322
146 ISCHAEMIC CARDIOMYOPATHY 98 0.0319
147 DRY MOUTH 2565 0.0316
148 CHEST DISCOMFORT 3231 0.0315
149 COUGH 8787 0.0313
150 NEUROLOGICAL SYMPTOM 179 0.0313
151 MACULAR DEGENERATION 373 0.0312
152 BLOOD PRESSURE SYSTOLIC ABNORMAL 77 0.0311
153 URINE FLOW DECREASED 74 0.0309
154 LUNG NEOPLASM MALIGNANT 1273 0.0309
155 PULMONARY ALVEOLAR HAEMORRHAGE 173 0.0308
156 MULTIPLE ALLERGIES 241 0.0307
157 SEASONAL ALLERGY 428 0.0302
158 OXYGEN SATURATION DECREASED 1667 0.0296
159 CARDIAC MURMUR 256 0.0296
160 NEPHROGENIC ANAEMIA 137 0.0295
161 PNEUMONIA VIRAL 94 0.0295
162 PHARYNGOLARYNGEAL PAIN 156 0.0293
163 OXYGEN CONSUMPTION INCREASED 70 0.0293
164 TONGUE DISCOLOURATION 128 0.0292
165 RESPIRATORY DISORDER 861 0.0288
166 RESPIRATORY TRACT INFECTION 744 0.0285
167 ORAL FUNGAL INFECTION 78 0.0285
168 HAEMORRHAGIC ANAEMIA 125 0.0284
169 LOWER RESPIRATORY TRACT INFECTION 1287 0.0283
170 BLOOD TEST ABNORMAL 393 0.0279
171 ATELECTASIS 270 0.0279
172 HYPOXIA 983 0.0279
173 NODULE 361 0.0276
174 BRONCHIOLITIS 97 0.0275
175 BLOOD PRESSURE DIASTOLIC ABNORMAL 70 0.0275
176 GLOSSITIS 97 0.0273
177 SNORING 103 0.0272
178 VASCULITIS 317 0.0272
179 PULMONARY FIBROSIS 518 0.0270
180 LUNG NEOPLASM 114 0.0267
181 PNEUMONIA 8561 0.0264
182 CUSHINGOID 84 0.0261
183 CHOKING 492 0.0252
184 NASAL CONGESTION 1479 0.0251
185 CREPITATIONS 74 0.0248
186 EXERCISE TOLERANCE DECREASED 142 0.0246
187 HYPOPNOEA 85 0.0245
188 LYMPHOEDEMA 169 0.0244
189 PNEUMOTHORAX 386 0.0243
190 INTENTIONAL DEVICE MISUSE 107 0.0242
191 UPPER RESPIRATORY TRACT CONGESTION 70 0.0242
192 AORTIC STENOSIS 84 0.0241
193 HEART VALVE INCOMPETENCE 69 0.0241
194 AORTIC ANEURYSM 183 0.0240
195 SINUS DISORDER 474 0.0239
196 UMBILICAL HERNIA 111 0.0237
197 UPPER RESPIRATORY TRACT INFECTION 1090 0.0236
198 URINARY RETENTION 778 0.0233
199 REBOUND ACID HYPERSECRETION 70 0.0231
200 CANDIDA INFECTION 385 0.0228
201 IMPAIRED QUALITY OF LIFE 326 0.0227
202 ACUTE RESPIRATORY FAILURE 436 0.0226
203 JAUNDICE CHOLESTATIC 80 0.0226
204 GLAUCOMA 434 0.0225
205 DYSLIPIDAEMIA 114 0.0224
206 SEDATION 586 0.0224
207 SINUS CONGESTION 296 0.0219
208 RIB FRACTURE 439 0.0213
209 RENAL FUNCTION TEST ABNORMAL 99 0.0213
210 INTERVERTEBRAL DISC DEGENERATION 195 0.0211
211 NASAL DRYNESS 132 0.0210
212 LEFT VENTRICULAR HYPERTROPHY 90 0.0210
213 HYPOMANIA 77 0.0209
214 ABDOMINAL HERNIA 95 0.0208
215 ASPIRATION 226 0.0206
216 THROAT IRRITATION 917 0.0204
217 GASTROOESOPHAGEAL REFLUX DISEASE 1644 0.0204
218 CATARACT 1211 0.0203
219 BLOOD PRESSURE DIASTOLIC DECREASED 149 0.0202
220 DECREASED ACTIVITY 216 0.0200
221 TONGUE DISORDER 144 0.0199
222 HYPERCHOLESTEROLAEMIA 186 0.0192
223 OROPHARYNGEAL PAIN 1782 0.0192
224 CHOKING SENSATION 106 0.0192
225 ATRIAL FLUTTER 151 0.0189
226 HEARING IMPAIRED 113 0.0188
227 LOWER GASTROINTESTINAL HAEMORRHAGE 139 0.0188
228 VIRAL UPPER RESPIRATORY TRACT INFECTION 89 0.0187
229 HIATUS HERNIA 242 0.0187
230 CAROTID ARTERY OCCLUSION 67 0.0183
231 PARANASAL SINUS DISCOMFORT 69 0.0182
232 PULMONARY HYPERTENSION 378 0.0181
233 HYPOTHYROIDISM 571 0.0179
234 DYSURIA 655 0.0178
235 RHINORRHOEA 1147 0.0177
236 FRUSTRATION TOLERANCE DECREASED 143 0.0177
237 ANEURYSM 88 0.0177
238 HYPERVENTILATION 102 0.0176
239 BODY HEIGHT DECREASED 188 0.0176
240 AGEUSIA 438 0.0175
241 MUSCULOSKELETAL CHEST PAIN 271 0.0175
242 WRIST FRACTURE 209 0.0174
243 PNEUMONIA BACTERIAL 159 0.0173
244 FOREIGN BODY 68 0.0170
245 SINUSITIS 1733 0.0169
246 DEPRESSED LEVEL OF CONSCIOUSNESS 667 0.0168
247 BUNDLE BRANCH BLOCK LEFT 71 0.0167
248 CARDIAC FAILURE CHRONIC 71 0.0166
249 CARDIAC FAILURE CONGESTIVE 1338 0.0166
250 BLOOD CALCIUM INCREASED 146 0.0166
251 INFLUENZA 1846 0.0165
252 RESPIRATORY SYNCYTIAL VIRUS INFECTION 144 0.0165
253 SKIN LACERATION 179 0.0164
254 CYSTITIS 524 0.0164
255 OBESITY 262 0.0164
256 RESPIRATORY FAILURE 1198 0.0164
257 PHARYNGEAL OEDEMA 252 0.0164
258 OESOPHAGEAL CANDIDIASIS 65 0.0163
259 SPINAL COLUMN STENOSIS 77 0.0163
260 LUNG INFILTRATION 144 0.0163
261 HEART RATE INCREASED 1607 0.0162
262 GOUT 291 0.0162
263 COGNITIVE DISORDER 756 0.0162
264 TRANSIENT ISCHAEMIC ATTACK 539 0.0160
265 JOINT INJURY 338 0.0158
266 MICTURITION URGENCY 180 0.0157
267 OSTEOPOROSIS 639 0.0155
268 ATRIAL FIBRILLATION 1494 0.0153
269 RIGHT VENTRICULAR FAILURE 107 0.0153
270 GLOSSODYNIA 340 0.0152
271 UPPER LIMB FRACTURE 302 0.0151
272 VIRAL INFECTION 504 0.0151
273 RESPIRATORY DISTRESS 418 0.0151
274 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 133 0.0150
275 FOOD ALLERGY 116 0.0150
276 POLYP 98 0.0150
277 NASOPHARYNGITIS 2755 0.0149
278 ARTERIAL OCCLUSIVE DISEASE 117 0.0149
279 TRICUSPID VALVE INCOMPETENCE 118 0.0148
280 NON-SMALL CELL LUNG CANCER 71 0.0148
281 SWOLLEN TONGUE 460 0.0147
282 EAR DISORDER 67 0.0146
283 PULMONARY THROMBOSIS 159 0.0146
284 FIBROMYALGIA 354 0.0145
285 OSTEOPENIA 219 0.0144
286 OROPHARYNGEAL DISCOMFORT 130 0.0144
287 ORAL PAIN 321 0.0143
288 ASPERGILLUS INFECTION 94 0.0143
289 OEDEMA PERIPHERAL 1745 0.0143
290 MITRAL VALVE INCOMPETENCE 161 0.0142
291 CORONARY ARTERY DISEASE 429 0.0142
292 PLEURISY 84 0.0141
293 LEFT VENTRICULAR DYSFUNCTION 94 0.0140
294 SNEEZING 314 0.0140
295 HAND FRACTURE 99 0.0140
296 CYSTIC FIBROSIS 77 0.0139
297 PSEUDOMONAS INFECTION 119 0.0139
298 ECCHYMOSIS 95 0.0138
299 MOBILITY DECREASED 992 0.0138
300 OVERWEIGHT 74 0.0138
301 POST PROCEDURAL INFECTION 112 0.0138
302 CLOSTRIDIUM DIFFICILE COLITIS 146 0.0138
303 SPINAL OSTEOARTHRITIS 120 0.0136
304 CATARACT OPERATION 81 0.0136
305 LACERATION 128 0.0136
306 TYPE 2 DIABETES MELLITUS 457 0.0136
307 ORAL DISCOMFORT 188 0.0135
308 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 73 0.0134
309 THROAT TIGHTNESS 362 0.0134
310 MUSCULOSKELETAL DISCOMFORT 229 0.0133
311 HYPOACUSIS 572 0.0133
312 HEART RATE IRREGULAR 300 0.0133
313 EAR DISCOMFORT 135 0.0131
314 LIGAMENT SPRAIN 130 0.0131
315 PHARYNGITIS 163 0.0131
316 SPINAL COMPRESSION FRACTURE 108 0.0130
317 BALANCE DISORDER 1128 0.0130
318 SKIN ATROPHY 75 0.0130
319 INTERVERTEBRAL DISC PROTRUSION 284 0.0130
320 PELVIC FRACTURE 101 0.0130
321 SINUS HEADACHE 77 0.0129
322 CHEST PAIN 2395 0.0129
323 VISUAL DISTURBANCE 74 0.0129
324 ADRENAL INSUFFICIENCY 156 0.0128
325 CORONARY ARTERY OCCLUSION 176 0.0128
326 DIABETES MELLITUS 977 0.0128
327 CONCOMITANT DISEASE AGGRAVATED 79 0.0128
328 HIP FRACTURE 410 0.0127
329 SENSATION OF FOREIGN BODY 107 0.0127
330 IRON DEFICIENCY ANAEMIA 117 0.0127
331 SUPRAVENTRICULAR TACHYCARDIA 121 0.0126
332 FLUID RETENTION 641 0.0126
333 INGUINAL HERNIA 76 0.0125
334 TROPONIN INCREASED 94 0.0123
335 CONCUSSION 95 0.0123
336 BLOOD PRESSURE INCREASED 1876 0.0123
337 INFUSION SITE SWELLING 77 0.0122
338 CARDIOMEGALY 150 0.0122
339 GINGIVAL PAIN 97 0.0122
340 ATRIOVENTRICULAR BLOCK 94 0.0121
341 POST-TRAUMATIC STRESS DISORDER 81 0.0121
342 CARDIAC VALVE DISEASE 69 0.0121
343 WEIGHT FLUCTUATION 126 0.0120
344 SPINAL FRACTURE 240 0.0120
345 FALL 3985 0.0120
346 NERVE COMPRESSION 110 0.0119
347 LOCALISED INFECTION 288 0.0119
348 HERNIA 230 0.0119
349 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 122 0.0119
350 ASPHYXIA 97 0.0119
351 PULMONARY OEDEMA 530 0.0118
352 PROSTATIC DISORDER 65 0.0118
353 VISION BLURRED 1616 0.0118
354 ANKLE FRACTURE 182 0.0117
355 SKIN LESION 321 0.0117
356 PULMONARY ARTERIAL HYPERTENSION 169 0.0117
357 NERVOUSNESS 609 0.0116
358 EXTRA DOSE ADMINISTERED 472 0.0116
359 LIMB INJURY 316 0.0116
360 PNEUMONITIS 316 0.0116
361 BLADDER DISORDER 115 0.0116
362 END STAGE RENAL DISEASE 211 0.0116
363 ODYNOPHAGIA 69 0.0115
364 GASTROENTERITIS VIRAL 208 0.0115
365 KIDNEY INFECTION 226 0.0115
366 UPPER GASTROINTESTINAL HAEMORRHAGE 193 0.0115
367 SCOLIOSIS 71 0.0114
368 URINE OUTPUT DECREASED 100 0.0114
369 INTERNATIONAL NORMALISED RATIO INCREASED 326 0.0114
370 FLANK PAIN 107 0.0114
371 ANGINA PECTORIS 327 0.0114
372 SCRATCH 120 0.0114
373 POOR QUALITY SLEEP 242 0.0112
374 HYPERKALAEMIA 393 0.0112
375 RENAL CYST 89 0.0112
376 DEMENTIA 313 0.0112
377 WEIGHT DECREASED 3120 0.0112
378 PAROSMIA 84 0.0111
379 PLEURAL EFFUSION 673 0.0110
380 HAEMATOMA 286 0.0110
381 STENT PLACEMENT 89 0.0110
382 DIZZINESS POSTURAL 107 0.0110
383 FEELING JITTERY 210 0.0110
384 CONSTIPATION 2399 0.0110
385 RENAL FAILURE ACUTE 466 0.0110
386 EPISTAXIS 820 0.0110
387 EAR PAIN 213 0.0109
388 ANGINA UNSTABLE 71 0.0109
389 BLOOD MAGNESIUM DECREASED 94 0.0109
390 EXTRASYSTOLES 76 0.0109
391 VENTRICULAR EXTRASYSTOLES 113 0.0109
392 PULMONARY HAEMORRHAGE 85 0.0109
393 APPETITE DISORDER 72 0.0108
394 BACTERIAL INFECTION 202 0.0108
395 GLUCOSE TOLERANCE IMPAIRED 64 0.0108
396 GASTROINTESTINAL HAEMORRHAGE 903 0.0108
397 EYE DISORDER 354 0.0108
398 BACK INJURY 117 0.0107
399 TACHYPNOEA 146 0.0107
400 CARDIAC PACEMAKER INSERTION 64 0.0107
401 HYPERTENSION 2270 0.0107
402 DIVERTICULUM 76 0.0107
403 PANIC REACTION 77 0.0107
404 RETCHING 227 0.0106
405 PHOTOPSIA 67 0.0106
406 CHRONIC KIDNEY DISEASE 804 0.0106
407 SHOCK HAEMORRHAGIC 86 0.0106
408 MALAISE 4629 0.0105
409 LOCAL SWELLING 184 0.0105
410 CARDIAC FAILURE 845 0.0105
411 ORAL DISORDER 77 0.0105
412 CARDIOMYOPATHY 155 0.0105
413 PERICARDIAL EFFUSION 242 0.0105
414 FOOT FRACTURE 198 0.0104
415 RENAL FAILURE CHRONIC 80 0.0104
416 HYPONATRAEMIA 585 0.0104
417 GROIN PAIN 91 0.0104
418 SLEEP DISORDER 731 0.0103
419 RESTLESS LEGS SYNDROME 188 0.0103
420 CHOLELITHIASIS 339 0.0103
421 PULMONARY EMBOLISM 982 0.0103
422 INFUSION SITE ERYTHEMA 87 0.0103
423 CELLULITIS 520 0.0103
424 EYE PAIN 582 0.0103
425 BURSITIS 125 0.0103
426 PHARYNGITIS STREPTOCOCCAL 111 0.0102
427 CONTUSION 986 0.0102
428 VISUAL ACUITY REDUCED 338 0.0102
429 OSTEOARTHRITIS 431 0.0102
430 BLOOD PRESSURE FLUCTUATION 244 0.0102
431 ECONOMIC PROBLEM 153 0.0101
432 HEART RATE DECREASED 354 0.0101
433 OEDEMA 545 0.0100
434 JOINT DISLOCATION 106 0.0100
435 TOOTH ABSCESS 102 0.0100
436 HYPOMAGNESAEMIA 139 0.0100
437 BLOOD SODIUM DECREASED 188 0.0100
438 SUDDEN DEATH 105 0.0099
439 TENDONITIS 153 0.0099
440 GENERAL PHYSICAL HEALTH DETERIORATION 1143 0.0099
441 ARTHRITIS 777 0.0099
442 LYMPHOMA 152 0.0098
443 ROTATOR CUFF SYNDROME 126 0.0098
444 CYANOSIS 154 0.0098
445 FUNGAL INFECTION 326 0.0098
446 BLOOD IRON DECREASED 116 0.0098
447 MYOCARDIAL ISCHAEMIA 111 0.0097
448 MUSCULOSKELETAL PAIN 509 0.0097
449 INTRAOCULAR PRESSURE INCREASED 124 0.0097
450 HYPOTENSION 1944 0.0097
451 CARPAL TUNNEL SYNDROME 134 0.0096
452 BLOOD POTASSIUM DECREASED 287 0.0095
453 POLLAKIURIA 398 0.0095
454 RENAL PAIN 101 0.0095
455 MUSCLE STRAIN 82 0.0095
456 NEUTROPHIL COUNT INCREASED 97 0.0095
457 ELECTROLYTE IMBALANCE 110 0.0095
458 NASAL DISCOMFORT 75 0.0095
459 WEIGHT INCREASED 2117 0.0094
460 MUSCLE ATROPHY 119 0.0094
461 PRURITUS GENERALISED 203 0.0094
462 HYPERLIPIDAEMIA 112 0.0094
463 EAR INFECTION 249 0.0093
464 DENTAL CARIES 103 0.0093
465 MELAENA 204 0.0093
466 MUSCLE DISORDER 75 0.0093
467 MASS 129 0.0092
468 EYE INFECTION 104 0.0092
469 SINUS TACHYCARDIA 130 0.0091
470 ANOSMIA 132 0.0091
471 DYSPHAGIA 865 0.0091
472 NEUTROPENIC SEPSIS 65 0.0091
473 THROMBOSIS 732 0.0091
474 SKIN INFECTION 102 0.0091
475 TREMOR 1509 0.0091
476 DYSGEUSIA 675 0.0091
477 INCREASED TENDENCY TO BRUISE 83 0.0090
478 FLUID OVERLOAD 131 0.0090
479 NOCTURIA 109 0.0090
480 WHITE BLOOD CELL COUNT INCREASED 344 0.0090
481 LACRIMATION INCREASED 270 0.0089
482 INTERNAL HAEMORRHAGE 102 0.0089
483 MEDICATION ERROR 496 0.0089
484 ASTHENIA 3354 0.0089
485 BACK DISORDER 145 0.0089
486 CARDIAC DISORDER 828 0.0088
487 RENAL FAILURE 1175 0.0088
488 ILL-DEFINED DISORDER 537 0.0088
489 ACUTE CORONARY SYNDROME 73 0.0088
490 MYOCARDIAL INFARCTION 1535 0.0088
491 DRUG ADMINISTRATION ERROR 270 0.0088
492 BONE DISORDER 159 0.0087
493 STOMATITIS 528 0.0087
494 GASTRITIS 229 0.0087
495 THYROID DISORDER 134 0.0087
496 PHARYNGEAL SWELLING 85 0.0087
497 TRANSFUSION 91 0.0087
498 PERIPHERAL SWELLING 1338 0.0087
499 URINARY TRACT INFECTION 1468 0.0086
500 EYE PRURITUS 289 0.0086
501 EYE SWELLING 319 0.0086
502 SENSORY LOSS 69 0.0086
503 DIVERTICULITIS 237 0.0085
504 TACHYCARDIA 759 0.0085
505 BLOOD PRESSURE DECREASED 567 0.0085
506 VITAMIN D DEFICIENCY 83 0.0085
507 IMMUNE SYSTEM DISORDER 112 0.0085
508 BACK PAIN 1971 0.0085
509 ACUTE KIDNEY INJURY 1297 0.0085
510 CONJUNCTIVITIS 157 0.0085
511 DEVICE MECHANICAL ISSUE 116 0.0085
512 PALLOR 230 0.0084
513 LIP SWELLING 281 0.0084
514 QUALITY OF LIFE DECREASED 113 0.0084
515 ANXIETY 2394 0.0084
516 ELECTROCARDIOGRAM ABNORMAL 66 0.0084
517 RECTAL HAEMORRHAGE 361 0.0084
518 SWELLING FACE 546 0.0084
519 NECK PAIN 468 0.0084
520 ARRHYTHMIA 395 0.0083
521 SPEECH DISORDER 437 0.0083
522 URINARY INCONTINENCE 247 0.0083
523 INFUSION SITE PAIN 107 0.0083
524 INFECTION 1201 0.0083
525 THERAPEUTIC RESPONSE DECREASED 503 0.0083
526 ROAD TRAFFIC ACCIDENT 347 0.0083
527 HAEMATEMESIS 210 0.0083
528 ILLNESS 852 0.0083
529 BLOOD URINE PRESENT 157 0.0083
530 DEAFNESS 216 0.0083
531 PURPURA 73 0.0082
532 STAPHYLOCOCCAL INFECTION 272 0.0082
533 ACTIVITIES OF DAILY LIVING IMPAIRED 163 0.0082
534 CONDITION AGGRAVATED 2503 0.0082
535 HERPES ZOSTER 471 0.0082
536 DISABILITY 162 0.0082
537 INTESTINAL OBSTRUCTION 308 0.0082
538 OESOPHAGITIS 89 0.0081
539 SCHIZOPHRENIA 99 0.0081
540 CHOLECYSTECTOMY 93 0.0081
541 TEMPERATURE INTOLERANCE 84 0.0081
542 PROSTATIC SPECIFIC ANTIGEN INCREASED 112 0.0081
543 ACUTE MYOCARDIAL INFARCTION 239 0.0081
544 FAECES DISCOLOURED 175 0.0081
545 PALPITATIONS 945 0.0081
546 ECZEMA 422 0.0081
547 LIMB DISCOMFORT 249 0.0080
548 COVID-19 PNEUMONIA 95 0.0080
549 NEPHROPATHY 75 0.0080
550 CARDIAC OPERATION 69 0.0080
551 ESCHERICHIA INFECTION 66 0.0080
552 EYE DISCHARGE 83 0.0080
553 PRODUCT PRESCRIBING ERROR 190 0.0080
554 HEAD DISCOMFORT 141 0.0080
555 HEPATIC STEATOSIS 148 0.0079
556 BODY TEMPERATURE INCREASED 162 0.0079
557 COLON CANCER 118 0.0079
558 POST PROCEDURAL COMPLICATION 152 0.0079
559 HYPOKALAEMIA 365 0.0079
560 BLOOD PRESSURE ABNORMAL 156 0.0078
561 DYSPEPSIA 771 0.0078
562 ABSCESS 125 0.0078
563 VITREOUS FLOATERS 77 0.0078
564 PRESYNCOPE 190 0.0078
565 PNEUMONIA ASPIRATION 195 0.0078
566 TENDERNESS 81 0.0078
567 ANAEMIA 1482 0.0078
568 DEVICE DELIVERY SYSTEM ISSUE 212 0.0077
569 GAIT DISTURBANCE 1482 0.0077
570 DRY EYE 386 0.0077
571 PAIN IN EXTREMITY 2277 0.0077
572 SMALL INTESTINAL OBSTRUCTION 95 0.0077
573 IMMUNODEFICIENCY 115 0.0077
574 TOOTH EXTRACTION 96 0.0077
575 TINNITUS 354 0.0077
576 COAGULOPATHY 128 0.0077
577 ABNORMAL DREAMS 212 0.0077
578 RETINAL DETACHMENT 70 0.0076
579 SPINAL DISORDER 72 0.0076
580 BLOOD UREA INCREASED 127 0.0076
581 ACCIDENT 90 0.0075
582 LEUKAEMIA 71 0.0075
583 MULTI-ORGAN FAILURE 130 0.0075
584 SYNCOPE 747 0.0075
585 BLOOD POTASSIUM INCREASED 121 0.0074
586 GAIT INABILITY 249 0.0074
587 HYPERSENSITIVITY 1383 0.0074
588 VENTRICULAR TACHYCARDIA 123 0.0074
589 HYPOKINESIA 108 0.0074
590 DIZZINESS 3697 0.0074
591 ABASIA 183 0.0074
592 NEURALGIA 180 0.0074
593 HYPERSOMNIA 212 0.0074
594 FACIAL PAIN 66 0.0074
595 HYPOPHAGIA 189 0.0074
596 BEDRIDDEN 97 0.0074
597 IMMUNOSUPPRESSION 65 0.0074
598 PYREXIA 2545 0.0073
599 LYMPHADENOPATHY 260 0.0073
600 EYE HAEMORRHAGE 98 0.0073
601 INSOMNIA 1936 0.0073
602 HEAD INJURY 230 0.0073
603 BIPOLAR DISORDER 79 0.0073
604 GASTRIC ULCER 138 0.0073
605 RESPIRATORY ARREST 200 0.0072
606 VISUAL IMPAIRMENT 899 0.0072
607 CYST 90 0.0072
608 MALNUTRITION 81 0.0072
609 RENAL TUBULAR NECROSIS 71 0.0072
610 DRUG PRESCRIBING ERROR 139 0.0072
611 BLOOD CHOLESTEROL INCREASED 337 0.0072
612 DRUG INEFFECTIVE 9516 0.0072
613 WOUND INFECTION 79 0.0072
614 ANAPHYLACTIC REACTION 398 0.0072
615 DEHYDRATION 957 0.0072
616 PHARMACEUTICAL PRODUCT COMPLAINT 186 0.0072
617 PARAESTHESIA ORAL 103 0.0071
618 GASTROINTESTINAL INFECTION 64 0.0071
619 SCIATICA 113 0.0071
620 MUSCLE SPASMS 1298 0.0071
621 HAEMATURIA 242 0.0071
622 INTERSTITIAL LUNG DISEASE 342 0.0071
623 TOOTH INFECTION 93 0.0070
624 DRUG EFFECT DECREASED 380 0.0070
625 DEPRESSION 1605 0.0070
626 TENDON RUPTURE 87 0.0070
627 FEELING ABNORMAL 1685 0.0070
628 BLOOD CREATININE INCREASED 459 0.0070
629 MOUTH ULCERATION 148 0.0070
630 FATIGUE 5465 0.0070
631 NERVE INJURY 78 0.0070
632 WOUND 196 0.0070
633 DRUG INTERACTION 1111 0.0070
634 DELIRIUM 243 0.0070
635 THIRST 125 0.0070
636 TOOTH FRACTURE 77 0.0070
637 PANIC ATTACK 254 0.0070
638 CLOSTRIDIUM DIFFICILE INFECTION 152 0.0070
639 GENERALISED OEDEMA 86 0.0069
640 RESPIRATORY DEPRESSION 85 0.0069
641 VENTRICULAR FIBRILLATION 77 0.0069
642 HEPATOMEGALY 68 0.0069
643 DEVICE FAILURE 105 0.0069
644 CHILLS 807 0.0069
645 PRODUCT TASTE ABNORMAL 93 0.0069
646 LEUKOCYTOSIS 124 0.0068
647 PAIN IN JAW 194 0.0068
648 SEPSIS 760 0.0068
649 ABDOMINAL DISTENSION 709 0.0068
650 DECREASED APPETITE 1576 0.0068
651 CEREBROVASCULAR ACCIDENT 1149 0.0068
652 MEMORY IMPAIRMENT 929 0.0068
653 FACE OEDEMA 114 0.0068
654 URTICARIA 1125 0.0067
655 HOSPITALISATION 1031 0.0067
656 DIPLOPIA 174 0.0067
657 COLD SWEAT 117 0.0066
658 CIRCULATORY COLLAPSE 113 0.0066
659 TREATMENT NONCOMPLIANCE 363 0.0066
660 ORAL HERPES 129 0.0066
661 POLYNEUROPATHY 79 0.0066
662 TOOTHACHE 119 0.0066
663 ULCER 103 0.0065
664 HAEMOGLOBIN DECREASED 663 0.0065
665 HAEMATOCRIT DECREASED 128 0.0064
666 INTENTIONAL PRODUCT MISUSE 565 0.0064
667 MIGRAINE 616 0.0064
668 HALLUCINATION 486 0.0064
669 HYPOAESTHESIA ORAL 97 0.0064
670 FEELING COLD 179 0.0064
671 SWELLING 600 0.0064
672 RENAL INJURY 190 0.0064
673 LOSS OF CONSCIOUSNESS 819 0.0064
674 BLINDNESS UNILATERAL 90 0.0064
675 CARDIAC ARREST 525 0.0064
676 EATING DISORDER 135 0.0063
677 RASH GENERALISED 164 0.0063
678 NIGHT SWEATS 204 0.0063
679 AMNESIA 411 0.0063
680 CONFUSIONAL STATE 1020 0.0063
681 HEADACHE 3955 0.0063
682 DISCOMFORT 384 0.0063
683 AGITATION 462 0.0063
684 TRANSAMINASES INCREASED 139 0.0062
685 DERMATITIS CONTACT 71 0.0062
686 FLATULENCE 353 0.0062
687 DEPRESSED MOOD 329 0.0062
688 INFLUENZA LIKE ILLNESS 512 0.0062
689 MUSCULAR WEAKNESS 706 0.0062
690 NEPHROLITHIASIS 284 0.0062
691 BLOOD BILIRUBIN INCREASED 167 0.0062
692 FEEDING DISORDER 125 0.0062
693 HAEMATOCHEZIA 340 0.0062
694 DIABETES MELLITUS INADEQUATE CONTROL 109 0.0062
695 ABDOMINAL PAIN 1432 0.0061
696 JOINT SWELLING 743 0.0061
697 HYPERCALCAEMIA 76 0.0061
698 DRUG DISPENSING ERROR 94 0.0061
699 UNEVALUABLE EVENT 465 0.0061
700 VERTIGO 374 0.0061
701 DYSSTASIA 179 0.0061
702 GASTRIC DISORDER 209 0.0061
703 LOWER LIMB FRACTURE 117 0.0061
704 ABDOMINAL PAIN UPPER 1250 0.0061
705 INCREASED APPETITE 116 0.0061
706 OCULAR HYPERAEMIA 288 0.0061
707 PHOTOPHOBIA 114 0.0061
708 INCONTINENCE 64 0.0060
709 ANOREXIA 78 0.0060
710 BRADYCARDIA 321 0.0060
711 FOOT DEFORMITY 67 0.0060
712 HYPOGLYCAEMIA 292 0.0060
713 RASH PRURITIC 325 0.0060
714 HYPERHIDROSIS 770 0.0060
715 DEVICE MALFUNCTION 420 0.0060
716 GLOMERULAR FILTRATION RATE DECREASED 73 0.0059
717 BLINDNESS 242 0.0059
718 OVERDOSE 1276 0.0059
719 SARS-COV-2 TEST POSITIVE 78 0.0059
720 MALIGNANT MELANOMA 79 0.0059
721 IMPAIRED DRIVING ABILITY 67 0.0059
722 SCAB 67 0.0059
723 HYPOCALCAEMIA 111 0.0059
724 ANAPHYLACTIC SHOCK 151 0.0059
725 MYALGIA 995 0.0058
726 HAEMORRHOIDS 114 0.0058
727 BLOOD GLUCOSE FLUCTUATION 64 0.0058
728 PHOTOSENSITIVITY REACTION 96 0.0058
729 DRUG EFFECT INCOMPLETE 211 0.0058
730 CHROMATURIA 131 0.0058
731 ARTHRALGIA 2410 0.0058
732 DRUG DOSE OMISSION 958 0.0058
733 FEELING HOT 354 0.0058
734 UNRESPONSIVE TO STIMULI 149 0.0058
735 INSURANCE ISSUE 88 0.0057
736 VOMITING 2702 0.0057
737 SUBDURAL HAEMATOMA 82 0.0057
738 EJECTION FRACTION DECREASED 89 0.0057
739 NIGHTMARE 197 0.0057
740 PAIN 3493 0.0057
741 BURNING SENSATION 397 0.0057
742 INFLAMMATION 292 0.0057
743 ILEUS 70 0.0056
744 RED BLOOD CELL COUNT DECREASED 161 0.0056
745 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 400 0.0056
746 SKIN ULCER 145 0.0056
747 PRURITUS 2155 0.0056
748 PANCREATITIS ACUTE 126 0.0056
749 NEOPLASM MALIGNANT 374 0.0056
750 RASH MACULAR 195 0.0056
751 MUSCULOSKELETAL STIFFNESS 488 0.0056
752 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1003 0.0056
753 RENAL DISORDER 259 0.0056
754 HYPOAESTHESIA 830 0.0055
755 SEPTIC SHOCK 241 0.0055
756 ERUCTATION 107 0.0055
757 PLATELET COUNT INCREASED 72 0.0055
758 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 257 0.0055
759 MULTIPLE FRACTURES 90 0.0055
760 OFF LABEL USE 4786 0.0055
761 FEAR 147 0.0055
762 LETHARGY 314 0.0055
763 MOVEMENT DISORDER 174 0.0054
764 SKIN DISCOLOURATION 249 0.0054
765 COLITIS 205 0.0054
766 ACCIDENTAL OVERDOSE 197 0.0054
767 LIVER FUNCTION TEST ABNORMAL 156 0.0054
768 C-REACTIVE PROTEIN INCREASED 195 0.0054
769 GASTROENTERITIS 78 0.0053
770 BASAL CELL CARCINOMA 83 0.0053
771 INTENTIONAL DRUG MISUSE 111 0.0053
772 BLISTER 298 0.0053
773 MENTAL STATUS CHANGES 147 0.0053
774 RENAL IMPAIRMENT 442 0.0053
775 HYPERTHYROIDISM 76 0.0052
776 BONE PAIN 307 0.0052
777 DIARRHOEA 3382 0.0052
778 FRACTURE 99 0.0052
779 SOMNOLENCE 1052 0.0052
780 RASH 2274 0.0052
781 PRODUCT USE ISSUE 979 0.0052
782 NAUSEA 4116 0.0052
783 SKIN HAEMORRHAGE 77 0.0052
784 DISORIENTATION 205 0.0052
785 PRESCRIBED OVERDOSE 100 0.0052
786 TOOTH LOSS 107 0.0052
787 SCAR 88 0.0051
788 ABDOMINAL DISCOMFORT 862 0.0051
789 SOPOR 68 0.0051
790 METASTASES TO CENTRAL NERVOUS SYSTEM 66 0.0051
791 PSYCHOTIC DISORDER 151 0.0051
792 FEMUR FRACTURE 158 0.0051
793 EYE IRRITATION 293 0.0051
794 RASH ERYTHEMATOUS 243 0.0051
795 HAEMORRHAGE 531 0.0051
796 NEUROPATHY PERIPHERAL 483 0.0051
797 HEPATOTOXICITY 113 0.0051
798 THINKING ABNORMAL 94 0.0050
799 INTENTIONAL PRODUCT USE ISSUE 439 0.0050
800 GALLBLADDER DISORDER 89 0.0050
801 DISEASE RECURRENCE 237 0.0050
802 GAMMA-GLUTAMYLTRANSFERASE INCREASED 110 0.0050
803 TOOTH DISORDER 110 0.0049
804 COVID-19 865 0.0049
805 TUBULOINTERSTITIAL NEPHRITIS 92 0.0049
806 MUSCLE TIGHTNESS 79 0.0049
807 DEVICE RELATED INFECTION 75 0.0049
808 HYPERGLYCAEMIA 177 0.0049
809 HEPATIC CIRRHOSIS 91 0.0048
810 MENTAL IMPAIRMENT 117 0.0048
811 HAEMORRHAGE INTRACRANIAL 72 0.0048
812 ENCEPHALOPATHY 118 0.0048
813 DEVICE DEFECTIVE 83 0.0048
814 ARTHROPATHY 266 0.0048
815 ADVERSE DRUG REACTION 429 0.0048
816 ANGIOEDEMA 211 0.0048
817 COMA 227 0.0048
818 HIP ARTHROPLASTY 73 0.0048
819 INFUSION RELATED REACTION 312 0.0047
820 INCORRECT DOSE ADMINISTERED 1072 0.0047
821 METABOLIC ACIDOSIS 150 0.0047
822 JOINT STIFFNESS 123 0.0047
823 APHASIA 141 0.0047
824 WRONG TECHNIQUE IN DRUG USAGE PROCESS 169 0.0046
825 DYSARTHRIA 175 0.0046
826 ANHEDONIA 122 0.0046
827 DRUG INTOLERANCE 447 0.0046
828 PRODUCT DOSE OMISSION 302 0.0046
829 ERYTHEMA 950 0.0046
830 LIVER FUNCTION TEST INCREASED 99 0.0046
831 ISCHAEMIC STROKE 82 0.0046
832 DEEP VEIN THROMBOSIS 297 0.0046
833 ASCITES 134 0.0046
834 RHABDOMYOLYSIS 190 0.0046
835 PARAESTHESIA 713 0.0045
836 OSTEOMYELITIS 82 0.0045
837 IRRITABLE BOWEL SYNDROME 96 0.0045
838 DEATH 3842 0.0045
839 CARDIO-RESPIRATORY ARREST 186 0.0044
840 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 150 0.0044
841 HEPATIC FAILURE 132 0.0044
842 SENSORY DISTURBANCE 70 0.0044
843 SURGERY 253 0.0043
844 RASH MACULO-PAPULAR 96 0.0043
845 PARANOIA 74 0.0043
846 DEVICE USE ERROR 149 0.0043
847 OSTEONECROSIS OF JAW 106 0.0043
848 BLOOD GLUCOSE ABNORMAL 79 0.0043
849 TOXICITY TO VARIOUS AGENTS 721 0.0043
850 BLOOD GLUCOSE DECREASED 205 0.0043
851 BLOOD ALKALINE PHOSPHATASE INCREASED 106 0.0043
852 PANCREATITIS 225 0.0043
853 CEREBRAL HAEMORRHAGE 152 0.0042
854 IMPAIRED HEALING 139 0.0042
855 SKIN CANCER 91 0.0042
856 PSYCHOMOTOR HYPERACTIVITY 70 0.0042
857 RESTLESSNESS 154 0.0042
858 MENTAL DISORDER 182 0.0042
859 PRODUCT AVAILABILITY ISSUE 95 0.0042
860 LIVER DISORDER 185 0.0042
861 ANGER 141 0.0042
862 PRODUCT DOSE OMISSION ISSUE 1223 0.0042
863 FLUSHING 420 0.0041
864 HEPATIC ENZYME INCREASED 281 0.0041
865 RHEUMATOID ARTHRITIS 468 0.0041
866 ABDOMINAL PAIN LOWER 104 0.0041
867 FREQUENT BOWEL MOVEMENTS 110 0.0041
868 GASTROINTESTINAL DISORDER 364 0.0041
869 LACTIC ACIDOSIS 131 0.0040
870 INJURY 283 0.0040
871 IMPAIRED WORK ABILITY 86 0.0040
872 OSTEONECROSIS 132 0.0040
873 HEMIPARESIS 68 0.0040
874 SKIN EXFOLIATION 336 0.0040
875 HOT FLUSH 297 0.0039
876 EMOTIONAL DISORDER 121 0.0039
877 KNEE ARTHROPLASTY 81 0.0038
878 PRODUCT ADMINISTRATION ERROR 77 0.0038
879 PANCYTOPENIA 212 0.0038
880 BLOOD TRIGLYCERIDES INCREASED 67 0.0038
881 IRRITABILITY 228 0.0038
882 EXPIRED PRODUCT ADMINISTERED 126 0.0038
883 THERAPEUTIC RESPONSE UNEXPECTED 169 0.0038
884 ALOPECIA 733 0.0037
885 PRODUCT USE IN UNAPPROVED INDICATION 924 0.0037
886 NERVOUS SYSTEM DISORDER 115 0.0037
887 BLOOD GLUCOSE INCREASED 692 0.0037
888 SKIN DISORDER 122 0.0037
889 THERAPEUTIC RESPONSE SHORTENED 121 0.0036
890 ALTERED STATE OF CONSCIOUSNESS 79 0.0036
891 CARDIOVASCULAR DISORDER 92 0.0036
892 DYSTONIA 70 0.0036
893 THROMBOCYTOPENIA 403 0.0036
894 MUCOSAL INFLAMMATION 93 0.0035
895 CONVULSION 201 0.0035
896 BREAST CANCER 325 0.0035
897 ASPARTATE AMINOTRANSFERASE INCREASED 185 0.0035
898 HEPATITIS 89 0.0035
899 DISTURBANCE IN ATTENTION 186 0.0034
900 PLATELET COUNT DECREASED 366 0.0034
901 PRODUCT COMPLAINT 87 0.0034
902 FULL BLOOD COUNT DECREASED 69 0.0034
903 INCORRECT DOSE ADMINISTERED BY DEVICE 89 0.0034
904 PROCEDURAL PAIN 94 0.0034
905 JAUNDICE 91 0.0034
906 DRY SKIN 449 0.0034
907 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 674 0.0033
908 AGGRESSION 166 0.0033
909 HALLUCINATION, VISUAL 70 0.0033
910 ALANINE AMINOTRANSFERASE INCREASED 203 0.0033
911 DRUG DOSE OMISSION BY DEVICE 258 0.0033
912 DERMATITIS 69 0.0033
913 MUSCLE TWITCHING 75 0.0033
914 THERAPY CESSATION 167 0.0032
915 PRODUCT DOSE OMISSION IN ERROR 92 0.0032
916 ADVERSE EVENT 298 0.0032
917 LEUKOPENIA 161 0.0032
918 STEVENS-JOHNSON SYNDROME 71 0.0032
919 CRYING 116 0.0032
920 MOOD ALTERED 87 0.0032
921 NEUTROPHIL COUNT DECREASED 130 0.0032
922 EMOTIONAL DISTRESS 385 0.0032
923 SUICIDAL IDEATION 290 0.0032
924 INTENTIONAL DOSE OMISSION 90 0.0032
925 UNDERDOSE 229 0.0031
926 BONE DENSITY DECREASED 98 0.0031
927 INJECTION SITE PRURITUS 208 0.0031
928 FEBRILE NEUTROPENIA 204 0.0031
929 DEVICE ISSUE 274 0.0031
930 CEREBRAL INFARCTION 74 0.0030
931 ELECTROCARDIOGRAM QT PROLONGED 108 0.0030
932 SHOCK 69 0.0030
933 INJECTION SITE SWELLING 226 0.0029
934 INTENTIONAL OVERDOSE 189 0.0029
935 RASH PAPULAR 66 0.0029
936 BLOOD CREATINE PHOSPHOKINASE INCREASED 84 0.0029
937 DYSKINESIA 118 0.0029
938 MOOD SWINGS 92 0.0029
939 ERECTILE DYSFUNCTION 74 0.0029
940 THERAPEUTIC PRODUCT EFFECT DECREASED 128 0.0029
941 SEIZURE 329 0.0028
942 DISEASE PROGRESSION 336 0.0028
943 PANCREATIC CARCINOMA 82 0.0028
944 ABNORMAL BEHAVIOUR 112 0.0028
945 NO ADVERSE EVENT 512 0.0028
946 GLYCOSYLATED HAEMOGLOBIN INCREASED 70 0.0028
947 SYSTEMIC LUPUS ERYTHEMATOSUS 97 0.0027
948 INCORRECT DRUG ADMINISTRATION DURATION 76 0.0027
949 PRODUCT SUBSTITUTION ISSUE 148 0.0026
950 INJECTION SITE MASS 95 0.0026
951 OESOPHAGEAL CARCINOMA 75 0.0025
952 INJECTION SITE BRUISING 201 0.0025
953 MALIGNANT NEOPLASM PROGRESSION 250 0.0024
954 PROSTATE CANCER 196 0.0024
955 WHITE BLOOD CELL COUNT DECREASED 263 0.0024
956 INJECTION SITE ERYTHEMA 297 0.0024
957 ACCIDENTAL EXPOSURE TO PRODUCT 243 0.0024
958 INJECTION SITE PAIN 721 0.0023
959 INJECTION SITE RASH 72 0.0023
960 HEPATIC FUNCTION ABNORMAL 86 0.0023
961 LABORATORY TEST ABNORMAL 66 0.0022
962 EPILEPSY 68 0.0022
963 THERAPY INTERRUPTED 158 0.0022
964 COLITIS ULCERATIVE 97 0.0022
965 PSORIASIS 282 0.0022
966 PLASMA CELL MYELOMA 84 0.0022
967 INJECTION SITE REACTION 141 0.0020
968 NEUTROPENIA 272 0.0020
969 THERAPY NON-RESPONDER 88 0.0020
970 NEOPLASM PROGRESSION 68 0.0020
971 BLADDER CANCER 115 0.0020
972 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 106 0.0019
973 PSORIATIC ARTHROPATHY 69 0.0017
974 DEVICE DIFFICULT TO USE 112 0.0017
975 WITHDRAWAL SYNDROME 70 0.0017
976 DERMATITIS ATOPIC 86 0.0016
977 RENAL CANCER 77 0.0016
978 INJECTION SITE HAEMORRHAGE 127 0.0016
979 DRUG ABUSE 132 0.0016
980 SUICIDE ATTEMPT 96 0.0016
981 SKIN BURNING SENSATION 112 0.0016
982 ACNE 112 0.0015
983 DRUG DEPENDENCE 231 0.0014
984 SKIN IRRITATION 65 0.0014
985 TREATMENT FAILURE 104 0.0013
986 PRODUCT STORAGE ERROR 103 0.0012
987 MATERNAL EXPOSURE DURING PREGNANCY 97 0.0011
988 EXPOSURE DURING PREGNANCY 64 0.0010
989 DRUG WITHDRAWAL SYNDROME 76 0.0009
990 COMPLETED SUICIDE 64 0.0008